New Assay Offers Largest Set of Apolipoproteins Commercially Available

Product News   May 03, 2017 | Original story from Bio-Rad

 
New Assay Offers Largest Set of Apolipoproteins Commercially Available

Credit: Bio-Rad

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Bio-Rad Launches a Range of Anti-idiotypic Antibodies Targeting Pembrolizumab and Nivolumab

Product News

Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced the launch of a range of anti-idiotypic antibodies targeting the immune checkpoint inhibitor drugs.

READ MORE

Cambridge Research Biochemicals to Support Preclinical Study on Treatment for Vision-Damaging Eye Disease

Product News

Under a new contract, Cambridge Research Biochemicals® will support evaluation of a potential new treatment approach for Fuchs Dystrophy, a disease that typically occurs in middle age and may cause a gradual loss of vision.

READ MORE

sphingotec is Adding an Advanced POC Testing Platform to Portfolio

Product News

POC testing of penKid® and bio-ADM® is set to add significant clinical benefit to emergency departments and intensive care units allowing on-site diagnosis, monitoring, and guidance in therapies of sepsis, decongestion in heart failure and acute kidney injury, thereby improving outcomes in acute heart failure, sepsis and other acute settings.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy